ArticleJournal of Zhejiang University. Science. B2022

Secondary donor-derived CD19 CAR-T therapy is safe and efficacious in acute lymphoblastic leukemia with extramedullary relapse after first autologous CAR-T therapy.

Delin Kong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.